Fcgr2b (FcγRII) - Model 580 Publications

Fcgr2b (FcγRII) - Model 580 Model Page

Filter publications by application: All
Filter publications by model type: All

Author(s)

(Date)

Paper Title

Citation

Model Type

Applications

Full Text

Sundgren NC, et al.
Mouse over for full list
Sundgren NC, Zhu W, Yuhanna IS, Chambliss KL, Ahmed M, Tanigaki K, Umetani M, Mineo C, Shaul PW
(2011) Coupling of Fcγ receptor I to Fcγ receptor IIb by SRC kinase mediates C-reactive protein impairment of endothelial function. Circ Res 109(10):1132-40
Tanigaki K, et al.
Mouse over for full list
Tanigaki K, Vongpatanasin W, Barrera JA, Atochin DN, Huang PL, Bonvini E, Shaul PW, Mineo C
(2013) C-reactive protein causes insulin resistance in mice through Fcγ receptor IIB-mediated inhibition of skeletal muscle glucose delivery. Diabetes 62(3):721-31
Sakunrangsit N, et al.
Mouse over for full list
Sakunrangsit N, Metheepakornchai P, Kumpunya S, Greenblatt MB, Leelahavanichkul A, Pisitkun P, Lotinun S
(2021) Etanercept prevents TNF-α mediated mandibular bone loss in FcγRIIb-/- lupus model. PLoS One 16(4):e0250215
McGaha TL, et al.
Mouse over for full list
McGaha TL, Sorrentino B, Ravetch JV
(2005) Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science 307(5709):590-3
Georgoudaki AM, et al.
Mouse over for full list
Georgoudaki AM, Prokopec KE, Boura VF, Hellqvist E, Sohn S, Östling J, Dahan R, Harris RA, Rantalainen M, Klevebring D, Sund M, Brage SE, Fuxe J, Rolny C, Li F, Ravetch JV, Karlsson MC
(2016) Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis. Cell Rep 15(9):2000-11
Bolland S, et al.
Mouse over for full list
Bolland S, Ravetch JV
(2000) Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 13(2):277-85
Takai T, et al.
Mouse over for full list
Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV
(1996) Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature 379(6563):346-9
Ono M, et al.
Mouse over for full list
Ono M, Bolland S, Tempst P, Ravetch JV
(1996) Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. Nature 383(6597):263-6
Nabbe KC, et al.
Mouse over for full list
Nabbe KC, Blom AB, Holthuysen AE, Boross P, Roth J, Verbeek S, van Lent PL, van den Berg WB
(2003) Coordinate expression of activating Fc gamma receptors I and III and inhibiting Fc gamma receptor type II in the determination of joint inflammation and cartilage destruction during immune complex-mediated arthritis. Arthritis Rheum. 48(1):255-65
Laine D, et al.
Mouse over for full list
Laine D, Trescol-Biémont MC, Longhi S, Libeau G, Marie JC, Vidalain PO, Azocar O, Diallo A, Canard B, Rabourdin-Combe C, Valentin H
(2003) Measles virus (MV) nucleoprotein binds to a novel cell surface receptor distinct from FcgammaRII via its C-terminal domain: role in MV-induced immunosuppression. J. Virol. 77(21):11332-46
Kim HY, et al.
Mouse over for full list
Kim HY, Kim S, Chung DH
(2006) FcgammaRIII engagement provides activating signals to NKT cells in antibody-induced joint inflammation. J. Clin. Invest. 116(9):2484-92
Curcio C, et al.
Mouse over for full list
Curcio C, Di Carlo E, Clynes R, Smyth MJ, Boggio K, Quaglino E, Spadaro M, Colombo MP, Amici A, Lollini PL, Musiani P, Forni G
(2003) Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas. J. Clin. Invest. 111(8):1161-70
Looney MR, et al.
Mouse over for full list
Looney MR, Su X, Van Ziffle JA, Lowell CA, Matthay MA
(2006) Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J. Clin. Invest. 116(6):1615-23
Wernersson S, et al.
Mouse over for full list
Wernersson S, Karlsson MC, Dahlström J, Mattsson R, Verbeek JS, Heyman B
(1999) IgG-mediated enhancement of antibody responses is low in Fc receptor gamma chain-deficient mice and increased in Fc gamma RII-deficient mice. J. Immunol. 163(2):618-22
Close

Welcome! Tell us a little about yourself